Tickerplace logo

Tickerplace

Virax Biolabs Group Limited logo

VRAXVirax Biolabs Group Limited

VRAX Stock Price, Valuation & Chart | Virax Biolabs Group Limited

Compare
$2.540-0.06 (-2.12%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyVRAX intrinsic valueVRAX calculated fair value vs price
OverviewFinancialsDividendsRatios

VRAX Historical price chart

VRAX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization474.96K
PE Ratio-0.04
EPS-61.75
Trading Volume19.24K
Today's High/Low2.61/2.54
Dividend Yield0.00
52 Week High/Low21.75/2.5
Shares Outstanding19.92M
VRAX Financial Statement
VRAX Analyst ratings
VRAX Analysis & performance metrics

VRAX Company profile

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection,…

VRAX Management team

Management
Lily Fu
Head of Supply Chain
Nigel McCracken M.Sc., Ph.D.COO
Chief Operating Officer & Director
Joel Yeung
Accounting Manager
Clement Monteil
Head of Scientific Research & Development
Jason D. DavisCFO
Chief Financial Officer
James FosterCEO
Chairman & Chief Executive Officer
Total 6 executives

VRAX Frequently asked questions

What is Virax Biolabs Group Limited (VRAX) Stock Price?

Current stock price of Virax Biolabs Group Limited (VRAX) stock is $2.540. The stock price is -2.12% lower in the session. The intraday range can be seen from this page. Volume of Virax Biolabs Group Limited (VRAX) stock is 19.24K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Virax Biolabs Group Limited (VRAX) stock price going up or down today?

The stock price of Virax Biolabs Group Limited (VRAX) can change with earnings, company news, and overall market sentiment. Virax Biolabs Group Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Virax Biolabs Group Limited stock expensive at its current price?

Whether Virax Biolabs Group Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VRAX on this page is -0.04. EPS on this page is -61.75. Compare those figures with peers and growth expectations before deciding if the current Virax Biolabs Group Limited price is justified.

How has the stock price of Virax Biolabs Group Limited (VRAX) performed historically?

Historical performance for Virax Biolabs Group Limited (VRAX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VRAX reacted to past earnings and market events.

Should I buy Virax Biolabs Group Limited (VRAX) stock, at this price?

Buying Virax Biolabs Group Limited (VRAX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.